• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Upstream Bio, Inc. - Common Stock (NQ:UPB)

    8.750 -4.050 (-31.64%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Upstream Bio, Inc. - Common Stock

    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    Which stocks are experiencing notable movement on Wednesday? ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Why Did UPB Stock Pop 20% In Pre-Market Today? ↗
    The company announced positive top-line results from its Phase 2 VALIANT trial evaluating Verekitug in adults with severe asthma. 
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
    The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
    Via Chartmill
    News headline image
    Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds ↗
    Upstream Bio's Phase 2 trial of verekitug in chronic rhinosinusitis met all endpoints, showing reduced nasal polyps, congestion, and need for surgery. 
    Via Benzinga
    News headline image
    Upstream Bio (UPB) Q2 R&D Soars 169% ↗
    Via The Motley Fool
    News headline image
    Alerus Financial Posts Better-Than-Expected Earnings, Joins Celcuity, SES AI, Abercrombie & Fitch And Other Big Stocks Moving Higher On Monday ↗
     
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency ↗
    The company is progressing with multiple Phase 2 trials for its investigational treatment targeting severe respiratory diseases. 
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
    From Upstream Bio
    Via GlobeNewswire
    News headline image
    Discover the 3 Best-Performing Biotech IPO Stocks of 2024
    Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise. 
    Via MarketBeat
    Topics Initial Public Offering
    News headline image
    Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say ↗
    Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market. 
    Via Benzinga
    News headline image
    This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
     
    Via Benzinga
    News headline image
    Another Trio Of Biotech IPOs Made Friday Debut ↗
    The Partners Group-backed KinderCare sold 24 million shares for $24 each this past Tuesday. Meanwhile, a new trio of biotech companies' shares came to market on Friday, as Upstream Bio, CeriBell, and... 
    Via Talk Markets
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.